Issue 9/2014
Content (7 Articles)
A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical Relevance
Hanne Haahr, Tim Heise
Impact of Cytochrome P450 2C19 Polymorphisms on Citalopram/Escitalopram Exposure: A Systematic Review and Meta-Analysis
Ming Chang, Gunnel Tybring, Marja-Liisa Dahl, Jonatan D. Lindh
A Population Pharmacokinetic and Pharmacodynamic Modelling Approach to Support the Clinical Development of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Dependence
Azmi F. Nasser, Christian Heidbreder, Roberto Gomeni, Paul J. Fudala, Bo Zheng, Mark K. Greenwald
Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition
Zhe-Yi Hu, Andrea N. Edginton, S. Casey Laizure, Robert B. Parker
Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine
Susanne Johansson, Jessica Read, Stuart Oliver, Mark Steinberg, Yan Li, Eleanor Lisbon, David Mathews, Philip T. Leese, Paul Martin
Vancomycin Pharmacokinetic and Pharmacodynamic Models for Critically Ill Patients with Post-Sternotomy Mediastinitis
Olivier Mangin, Saïk Urien, Jean-Luc Mainardi, Jean-Yves Fagon, Christophe Faisy